STUDY GOALS AND OBJECTIVES
The current report focuses on the rapid medical diagnostic kit (MDK) portion of the overall MDK market. Within the MDK market there are rapid kits, which in this report are defined as non-automated tests that provide results in two hours or less, MDK that require more than two hours to complete and MDK that are analyzed and read with the use of automation.
The analysis of the rapid market will include an overview of the MDK global market and the position of rapid MDK within that market; a technology review with a description of the types of rapid tests currently used and emerging technologies that will affect the market in the future; rapid tests for use in the clinical, home and veterinary markets, and an overview of current regulations and economic concerns that impact the market.
REASONS FOR DOING THE STUDY
The increasing use of rapid tests enables the clinician and the patient to receive test results quickly, usually within 30 minutes, and enable the clinician to prescribe the appropriate medications to treat an identified problem. In the past, clinicians relied on out-of-office laboratories that often took days to weeks to process tests. This left the clinician to begin treatment protocols without a clear diagnosis.
Several factors are driving the rapid MDK market.
An extremely large aging population of 78 million so-called Baby Boomers, who will demand quicker diagnosis and treatment.
Increasing rates of various types of cancer and the need for rapid confirmatory tests.
Continued threat of bioterrorism through chemical/biological methods and the need for rapid detection and early treatment.
An ever-increasing at-risk population of individuals with diabetes, hepatitis and human papillomavirus (HPV).
A slowdown in HIV/AIDS diagnosed cases, but still large numbers of individuals who have the disease but are unaware of it.
A virtual epidemic of substance abuse.
Introduction of infectious diseases from global migrations of people.
Reintroduction of infectious diseases such as syphilis, tuberculosis and measles, thought to be vanquished.
This report will identify and examine these marketplace trends and forecast future market changes from 2012 through 2017.
The current veterinary rapid MDK marketplace is highly competitive with dominance by less than four companies, but expanded competition on a regional basis.
The clinical market includes rapid tests for infectious diseases, cancer markers, pregnancy, drugs of abuse and diabetes.
The home-use market continues to expand with tests for human immunodeficiency virus (HIV), hepatitis, drugs of abuse, pregnancy and diabetes. This report includes blood glucose monitors and test strips for diabetes testing.
SCOPE OF REPORT
The report concentrates on rapid MDK and their position in the overall MDK market. The report specifically excludes tests that involve automated testing or tests that require processing devices and semi-automated batch testing devices.
The rapid MDK market encapsulates current and potential products, related technologies, components and component suppliers, end markets, governmental and regulatory agencies, major companies competing in this market, relative market shares and the impact of the worldwide market status.
Most Popular Stories
- 15 Myths That Could Ruin Your Hispanic Ad Campaign
- Bitcoin Clones Lurch Onto Financial Scene
- General Motors Names Mary Barra as First Female CEO
- AIG to Create 230 Jobs in Charlotte
- Clinton to Keynote Annual Simmons Leadership Conference
- How Bitcoin and Other Cryptocurrencies Work
- Californians Want to Legalize Marijuana
- Pacific Trade Pact Delay Hinders U.S. Pivot to Asia
- Budget Deal Sets Off Grumbles in Both Houses
- Russia Says Nyet to Canada North Pole Claim